BG Medicine, Inc. (OTCMKTS:BGMD) Short Interest Update

BG Medicine, Inc. (OTCMKTS:BGMD) was the recipient of a large growth in short interest in the month of May. As of May 28th, there was short interest totalling 3,200 shares, a growth of 1,500.0% from the May 13th total of 200 shares. Based on an average daily trading volume, of 101,600 shares, the days-to-cover ratio is presently 0.0 days.

BGMD stock traded up $0.03 during trading on Friday, hitting $0.08. The company had a trading volume of 6,600 shares, compared to its average volume of 25,667. The stock has a 50-day moving average price of $0.07. BG Medicine has a one year low of $0.01 and a one year high of $0.26.

BG Medicine Company Profile

BG Medicine, Inc engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.

Recommended Story: Stocks at 52 Week High

Receive News & Ratings for BG Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BG Medicine and related companies with MarketBeat.com's FREE daily email newsletter.